ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.8170G>T (p.Gly2724Trp) (rs1057521184)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000417977 SCV000521501 likely pathogenic not provided 2017-06-09 criteria provided, single submitter clinical testing The G2724W variant in the BRCA2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant was not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The G2724W variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution is conserved across species, and occurs within the DNA binding domain and DSS1 contacting residue (Yang et al., 2002). In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on currently available evidence, we consider G2724W to be a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.